Aduro Clean Technologies: Analyst’s $50 Price Target Could Be Just the Beginning

Aduro Clean Technologies (NASDAQ: ADUR) (CSE: ACT) (FSE: 9D50) is gaining momentum…

Small Pharma, Big Gains: The Power of Clinical Trial Results

For smaller pharmaceutical companies, valuation can be greatly impacted by progression in…

Aduro Clean Technologies and NexGen Polymers Sign Memorandum of Understanding to Collaborate on HCT Demonstration Plant

Collaboration will support feedstock logistics, site selection and regulatory planning as Aduro…

Light-Based Therapies Emerge as Promising Treatment for Parkinson’s Disease

In a landscape dominated by traditional pharmaceuticals and invasive treatments, novel light-based…

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology

Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug…

Aduro Clean Technologies Files New Patent Application on Novel Process Design

The new patent application covers a multi-functional process that integrates several off-the-shelf…